Welcome and Opening Remarks

Amy Gutmann, Ph.D.
Commission Chair James Wagner, Ph.D.
Commission Vice Chair

Session 1: Oversight of Emerging Technologies: Lessons from Prior Advisory Committee Efforts

- Ruth R. Faden, Ph.D.
Director
Johns Hopkins Berman Institute of Bioethics
Philip Franklin Wagley Professor of Biomedical Ethics and Professor Department of Health Policy & Management
Bloomberg School of Public Health Professor
Department of Medicine
Johns Hopkins University
- Alexander M. Capron, LL.B.
University Professor, Scott H. Bice Chair in Healthcare Law, Policy and Ethics, and Professor of Law Keck School of Medicine
Co-Director Pacific Center for Health Policy and Ethics
University of Southern California

Session 2: Synthetic Biology: What New Methods and Products are being Developed?

- James J. Collins, Ph.D.
University Professor, William F. Warren Distinguished Professor, Professor of Biomedical Engineering, and Co-Director Center for BioDynamics Boston University
Investigator Howard Hughes Medical Institute

- Ron Weiss, Ph.D.
Associate Professor
Department of Biological Engineering and Department of Electrical Engineering and Computer Science
Massachusetts Institute of Technology

Session 3: Knowledge Sharing, Innovation and Translating Research for the Public Good

- Arti K. Rai, J.D.
Professor Duke University School of Law

- Ashley J. Stevens, D.Phil.
Special Assistant to the Vice President of Research Office of Technology Development, and Senior Research Associate Institute for Technology Entrepreneurship and Commercialization Boston University
President Association of University Technology Managers

- David B. Weiner, Ph.D. Professor, Department of Pathology & Laboratory Medicine University of Pennsylvania
Chairman Scientific Advisory Board Inovio Pharmaceuticals

Session 4: Philosophical and Theological Perspectives

- Arthur L. Caplan, Ph.D.
Emmanuel and Robert Hart Director Center for Bioethics, and Sydney D. Caplan Professor of Bioethics School of Medicine University of Pennsylvania

- Ingrid Mattson, Ph.D.
Director Macdonald Center for the Study of Islam and Christian-Muslim Relations
Director Islamic Chaplaincy Program, and Professor of Islamic Studies and Christian-Muslim Relations Hartford Seminary
President Islamic Society of North America

- Sondra E. Wheeler, Ph.D.
Martha Ashby Carr Professor of Christian Ethics Wesley Theological Seminary

Session 5: Social Responsibility, Risk Assessment, and Ethics

- Bryan G. Norton, Ph.D.
Distinguished Professor of Philosophy School of Public Policy Georgia Institute of Technology

- Jonathan D. Moreno, Ph.D.
David and Lyn Silfen University Professor Professor, History and Sociology of Science Professor, Philosophy Professor of Medical Ethics, School of Medicine University of Pennsylvania

Closing Remarks

Amy Gutmann, Ph.D.
James Wagner, Ph.D.

Opening Remarks

Amy Gutmann, Ph.D.
James Wagner, Ph.D.

Session 6: Current Practices and Activities

- Randall D. Rettberg, M.S.
Director iGEM and MIT Registry of Standard Biological Parts/BioBricks
Principal Research Engineer Computer Science and Artificial Intelligence Laboratory Department of Biological Engineering Massachusetts Institute of Technology

- Jason Bobe, M.S.I.S.
Director of Community Personal Genome Project Harvard Medical School
Co-Founder DIYbio.org

Session 7: Biosecurity and Biosafety

- David A. Relman, M.D.
Thomas M. and Joan C. Merigan Professor of Medicine Chief, Division of Infectious Diseases, Department of Medicine Professor, Department of Microbiology and Immunology Stanford University School of Medicine
Chief of Infectious Diseases Veterans Administration Palo Alto Health Care System
Chair, Working Group on Synthetic Biology National Science Advisory Board for Biosecurity

- Damon Terrill, J.D., M.A.
Senior Vice President and General Counsel for International Legal and Regulatory Affairs Integrated DNA Technologies
President and Chief Operating Officer International Consortium for Polynucleotide Synthesis
Representative International Gene Synthesis Consortium

- Ralf Wagner, Ph.D.
Chief Executive Officer and Chief Science Officer Geneart AG
Professor and Chief Molecular Microbiology and Gene Therapy University of Regensburg Institute of Medical Microbiology & Hygiene

Session 8: Reflections for the Future

- Sydney Brenner, M.D., D.Phil.
Senior Distinguished Fellow of the Crick-Jacobs Center The Salk Institute

& Concluding Remarks
Amy Gutmann, Ph.D.
James Wagner, Ph.D.